Risking health to avoid injections: Preferences of Canadians with type 2 diabetes

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2243-2245

  Hauber, A Brett ^a   Johnson, F Reed ^a   Sauriol, Luc ^b   Lescrauwaet, Benedicte ^c  

^a RTI HEALTH SOLUTIONS   (United States)

^b Sanofi Avenus Pharmaceuticals   (Canada)

^c Pfizer Canada Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CANADA; CLINICAL FEATURE; CULTURAL ANTHROPOLOGY; DIABETES CONTROL; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 24144436200     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2243     Document Type: Article

References (13)

1. Diabetes Control and Complications Trial (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:997-986, 1993
2. Ohkubo Y, Kishakawa H, Araki E, Miyata T, Isami S, Motoyoshu S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6 year study. Diabetes Res Clin Pract 8: 103-117, 1995
3. United Kingdom Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
4. Hunt LM, Valenzuela MA, Pugh JA: NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care 20:292-298, 1997
5. Korytkowski M: When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 26 (Suppl. 3): S18-S24, 2002
6. Johnson FR, Desvousges WH: Estimating stated preferences with rated-pair data: environmental, health, and employment effects of energy programs. J Environ Econ Manage 34:79-99, 1997
7. Ryan M, Hughes J: Using conjoint analysis to value surgical versus medical management of miscarriage. Health Econ 6:261-273, 1997
8. Johnson FR, Desvousges WH, Ruby MC, Stieb D, De Civita P: Eliciting stated preferences: an application to willingness to pay for longevity. Med Decis Mak 18 (Suppl. 2):S57-S67, 1998
9. Ryan M, McIntosh E, Shackley P: Methdological issues in the application of conjoint analysis in health care. Health Econ Lett 2:15-21, 1998
10. Johnson FR, Banzhaf MR, Desvousges WH: Willingness to pay for improved respiratory and cardiovascular health: a multiple-format stated-preference approach. Health Econ 9:295-317, 2000
11. Zwerina K, Huber J, Kuhfeld WK: A general method for constructing efficient choice designs [article online]. SAS Institute Market Research Document TS-689D, 1996. Available from http://support.sas.com/techsup/ tnote/tnote_stat.html. Accessed 1 April 2005
12. Roper Starch Worldwide: Survey of Canadian Diabetes Market. New York, Roper ASW, 2002
13. Hosmer DW, Lemeshow S: Applied logistic regression. In Probability and Statistics. 2nd ed. New York, John Wiley & Sons, 2000